2011
DOI: 10.1016/s0140-6736(11)60342-5
|View full text |Cite
|
Sign up to set email alerts
|

Cholinesterase inhibitor treatment in patients with delirium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…31 The study assessed the use of rivastigmine in critically ill patients admitted to the intensive care unit; however, the authors noted that rivastigmine did not decrease the duration of delirium and may have actually increased patient mortality, leading to halting of the study. 31 There were some problems and concerns voiced about the trial, including the design of the study and subject selection, 32,33 but these results have prompted fresh concerns about this treatment approach, especially in critically ill patients. Furthermore, almost one-third (29%) of the patients cannot take these memory-enhancing drugs due to gastrointestinal side effects, such as nausea, vomiting, and diarrhea.…”
Section: Discussionmentioning
confidence: 99%
“…31 The study assessed the use of rivastigmine in critically ill patients admitted to the intensive care unit; however, the authors noted that rivastigmine did not decrease the duration of delirium and may have actually increased patient mortality, leading to halting of the study. 31 There were some problems and concerns voiced about the trial, including the design of the study and subject selection, 32,33 but these results have prompted fresh concerns about this treatment approach, especially in critically ill patients. Furthermore, almost one-third (29%) of the patients cannot take these memory-enhancing drugs due to gastrointestinal side effects, such as nausea, vomiting, and diarrhea.…”
Section: Discussionmentioning
confidence: 99%
“…A number of agents have been looked at for prophylaxis of delirium including haloperidol, risperidone, olanzapine and the cholinesterase inhibitor rivastigmine [67]. At present there is no convincing, reproducible evidence that any of these are clearly effective in the prevention of delirium.…”
Section: Preventionmentioning
confidence: 99%